Combination solution for treating chemotherapy refractory cancer
US12257227B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 12, 2019 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Jul 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of a pharmaceutical composition in treating cancer in a subject comprising a therapeutically effective amount of a compound of formula (I), a therapeutically effective amount of paclitaxel and a low dose of gemcitabine, and a kit included above composition thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.